Advanced search
Publication Cover
Vascular Health and Risk Management Volume 19, 2023 - Issue
Submit an article Journal homepage
231
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist

Si Dung Chu1 Haiphong - Vinhbao International General Hospital, Hai Phong City, Vietnam;2 Internal Medicine Department, Vietnam University of Traditional Medicine, Hanoi Capital, VietnamCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7723-5893View further author information
ORCID Icon &
Minh Thi Tran2 Internal Medicine Department, Vietnam University of Traditional Medicine, Hanoi Capital, VietnamView further author information
Pages 663-672 | Received 19 Jul 2023, Accepted 05 Oct 2023, Published online: 18 Oct 2023

References

  • Vos M, Esposito G, Edirisinghe JN, et al. Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency. Science. 2012;336(6086):1306–1310. doi:10.1126/science.1218632
  • Watson HG, Baglin T, Laidlaw SL, et al. A comparison of the effectiveness and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol. 2001;115(1):145–149. doi:10.1046/j.1365-2141.2001.03070.x
  • Palareti G, Leali N, Cocheri S, et al. Bleeding complications of oral anticoagulation treatment: an inception – cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy. Lancet. 1996;348(9025):423–428. doi:10.1016/S0140-6736(96)01109-9
  • Eichinger S. Reversing vitamin K antagonists: making the old new again. Am Soc Hematol. 2016;1(1):605–611. doi:10.1182/asheducation-2016.1.605
  • Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167(13):1414–1419. doi:10.1001/archinte.167.13.1414
  • Steffel J, Collins R, Antz M, et al. The 2021 European heart rhythm Association practical guide on the use of non – vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace. 2021;23(10):1612–1676. doi:10.1093/europace/euab065
  • Shah M, Tsadok MA, Jackevicius CA, et al. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation. 2014;129(11):1196–1203. doi:10.1161/CIRCULATIONAHA.113.004777
  • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151. doi:10.1056/NEJMoa0905561
  • Koutrouvelis A, Abouleish A, Indrikovs A, et al. Case scenario: emergency reversal of oral anticoagulation. Anesthesiology. 2010;113(5):1192–1197. doi:10.1097/ALN.0b013e3181f7a7a3
  • Gunther GE, Conway G, Leibach L, et al. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Thromb Res. 2004;113(3–4):205–209. doi:10.1016/j.thromres.2004.03.004
  • Bhatia HS, Hsu JC, Kim RJ. Atrial fibrillation and chronic kidney disease: a review of options for therapeutic anticoagulation to reduce thromboembolism risk. Clin Cardiol. 2018;41(10):1395–1402. doi:10.1002/clc.23085
  • Lee J, Kim BJ, Kim E, et al. Dissipation kinetics and the pre-harvest residue limits of acetamiprid and chlorantraniliprole in kimchi cabbage using ultra-performance liquid chromatography-tandem mass spectrometry. Molecules. 2019;24(14):2616. doi:10.3390/molecules24142616
  • O’Sullivan SM, Galvin K, Heneghan C, et al. Does daily consumption of vitamin K1 from cruciferous vegetables reach the circulation and the knee joint? Proc Nutr Soc. 2018; 77: E68.
  • Kurosu M, Began E. Vitamin K2 in electron transport system: are enzymes involved in vitamin k2 biosynthesis promising drug targets? Molecules. 2010;15(3):1531–1553. doi:10.3390/molecules15031531
  • Davis E, Darais D, Fuji K, et al. Prescribing and safety of direct-acting oral anticoagulants compared to warfarin in patients with atrial fibrillation on chronic hemodialysis. Pharmacy. 2020;8(1):37. doi:10.3390/pharmacy8010037
  • Aktan A, Güzel T, Aslan B, et al. Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: insight from the AFTER-2 trial. Cardiol Pol. 2023;81(2):132–140.
  • Aktan A, Guzel T, Arslan B, et al. The effect of COVID-19 pandemic on time in therapeutic range in patients using warfarin. Int J Cardiovasc Acad. 2022;8(1):20. doi:10.4103/ijca.ijca_54_21
  • Fotino A, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr. 2013;97(2):268–275. doi:10.3945/ajcn.112.040741
  • Qu H, Guo M, Chai H, et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(19):e009835. doi:10.1161/JAHA.118.009835
  • Ashirova ZB, Kuzhantaeva ZZ, Abdrassulova ZT, et al. Studying phytochemical features of three Asteraceae herbs growing wild in Kazakhstan. Floresta e Ambiente. 2021;28(4):e20210060. doi:10.1590/2179-8087-floram-2021-0060
  • Michel J, Abb Rani NZ, Husain K. A review on the potential use of medicinal plants from Asteraceae and Lamiaceae plant family in cardiovascular diseases. Pharmacol. 2020;11(852):1–26.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.